Ying J - Search Results

1

Establishment and validation of a multigene model to predict the risk of relapse in hormone receptor-positive early-stage Chinese breast cancer patients.

Liu J, Zhao S, Yang C, Ma L, Wu Q, Meng X, Zheng B, Guo C, Feng K, Shang Q, Liu J, Wang J, Zhang J, Shan G, Xu B, Liu Y, Ying J, Wang X, Wang X. Liu J, et al. Among authors: ying j. Chin Med J (Engl). 2023 Jan 20;136(2):184-193. doi: 10.1097/CM9.0000000000002411. Chin Med J (Engl). 2023. PMID: 36921106 Free PMC article.

2

[Immunophenotypes and gene mutations in colorectal precancerous lesions and adenocarcinoma].

Huang WT, Qiu T, Ling Y, Shi SS, Guo L, Zheng B, Lü N, Ying JM. Huang WT, et al. Zhonghua Bing Li Xue Za Zhi. 2013 Oct;42(10):655-9. Zhonghua Bing Li Xue Za Zhi. 2013. PMID: 24433726 Chinese.

3

Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status in invasive breast cancer: a 3,198 cases study at National Cancer Center, China.

Zhu X, Ying J, Wang F, Wang J, Yang H. Zhu X, et al. Among authors: ying j. Breast Cancer Res Treat. 2014 Oct;147(3):551-5. doi: 10.1007/s10549-014-3136-y. Epub 2014 Sep 19. Breast Cancer Res Treat. 2014. PMID: 25234844

4

C-MYC overexpression predicts aggressive transformation and a poor outcome in mucosa-associated lymphoid tissue lymphomas.

Huang W, Guo L, Liu H, Zheng B, Ying J, Lv N. Huang W, et al. Among authors: ying j. Int J Clin Exp Pathol. 2014 Aug 15;7(9):5634-44. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 25337204 Free PMC article.

5

[Correlation between BRAF V600E mutation and clinicopathologic features of papillary thyroid carcinoma].

Lu H, Qiu T, Ying J, Guo C, Lyn N. Lu H, et al. Among authors: ying j. Zhonghua Bing Li Xue Za Zhi. 2014 Dec;43(12):794-8. Zhonghua Bing Li Xue Za Zhi. 2014. PMID: 25623974 Chinese.

6

Prevalence and Clinicopathological Characteristics of HER2 and BRAF Mutation in Chinese Patients with Lung Adenocarcinoma.

Shan L, Qiu T, Ling Y, Guo L, Zheng B, Wang B, Li W, Li L, Ying J. Shan L, et al. Among authors: ying j. PLoS One. 2015 Jun 23;10(6):e0130447. doi: 10.1371/journal.pone.0130447. eCollection 2015. PLoS One. 2015. PMID: 26102513 Free PMC article.

7

Concurrence of EGFR amplification and sensitizing mutations indicate a better survival benefit from EGFR-TKI therapy in lung adenocarcinoma patients.

Shan L, Wang Z, Guo L, Sun H, Qiu T, Ling Y, Li W, Li L, Liu X, Zheng B, Lu N, Ying J. Shan L, et al. Among authors: ying j. Lung Cancer. 2015 Sep;89(3):337-42. doi: 10.1016/j.lungcan.2015.06.008. Epub 2015 Jun 19. Lung Cancer. 2015. PMID: 26141217

8

High frequency of clonal IG and T-cell receptor gene rearrangements in histiocytic and dendritic cell neoplasms.

Huang W, Qiu T, Zeng L, Zheng B, Ying J, Feng X. Huang W, et al. Among authors: ying j. Oncotarget. 2016 Nov 29;7(48):78355-78362. doi: 10.18632/oncotarget.13058. Oncotarget. 2016. PMID: 27823979 Free PMC article.

9

Genome wide copy number analyses of superficial esophageal squamous cell carcinoma with and without metastasis.

Wang P, Shan L, Xue L, Zheng B, Ying J, Lu N. Wang P, et al. Among authors: ying j. Oncotarget. 2017 Jan 17;8(3):5069-5080. doi: 10.18632/oncotarget.13847. Oncotarget. 2017. PMID: 27974698 Free PMC article.

10

[A systematic review of international simulation models on the natural history of breast cancer: current understanding and challenges for Chinese-population-specific model development].

Ma HM, Wang L, Shi JF, Ying JM, Zhu J, Chen LL, Yue XP, Gong JY, Li X, Wang JL, Dai M. Ma HM, et al. Among authors: ying jm. Zhonghua Liu Xing Bing Xue Za Zhi. 2017 Oct 10;38(10):1419-1425. doi: 10.3760/cma.j.issn.0254-6450.2017.10.025. Zhonghua Liu Xing Bing Xue Za Zhi. 2017. PMID: 29060992 Review. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,012 results

Search Page